GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Cyclically Adjusted PS Ratio

Dai Han Pharmaceutical Co (XKRX:023910) Cyclically Adjusted PS Ratio : 0.95 (As of Jun. 20, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-20), Dai Han Pharmaceutical Co's current share price is ₩28150.00. Dai Han Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩29,510.00. Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 0.95.

The historical rank and industry rank for Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:023910' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.92   Med: 1.43   Max: 2.79
Current: 0.96

During the past years, Dai Han Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 2.79. The lowest was 0.92. And the median was 1.43.

XKRX:023910's Cyclically Adjusted PS Ratio is ranked better than
72.01% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs XKRX:023910: 0.96

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dai Han Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩8,337.691. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩29,510.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dai Han Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Dai Han Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.50 1.46 1.16 1.13 0.95

Dai Han Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.98 0.95 0.95 0.96

Competitive Comparison of Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Dai Han Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=28150.00/29510
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dai Han Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Dai Han Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8337.691/118.8477*118.8477
=8,337.691

Current CPI (Mar. 2024) = 118.8477.

Dai Han Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4,665.337 99.353 5,580.753
201409 4,812.700 99.608 5,742.293
201412 4,719.144 99.098 5,659.644
201503 4,934.659 99.720 5,881.196
201506 5,322.299 100.050 6,322.269
201509 5,242.017 100.110 6,223.171
201512 5,213.735 100.220 6,182.802
201603 5,691.415 100.560 6,726.448
201606 5,843.603 100.790 6,890.552
201609 5,719.165 101.460 6,699.286
201612 5,978.670 101.560 6,996.368
201703 5,799.996 102.850 6,702.151
201706 5,956.519 102.610 6,899.119
201709 6,483.643 103.490 7,445.802
201712 5,834.931 102.990 6,733.354
201803 6,578.054 104.100 7,509.958
201806 6,460.222 104.130 7,373.308
201809 6,696.725 105.650 7,533.274
201812 6,718.472 104.350 7,651.892
201903 6,505.553 104.490 7,399.464
201906 7,065.646 104.880 8,006.634
201909 7,240.003 105.200 8,179.256
201912 7,313.384 105.120 8,268.444
202003 7,126.088 105.540 8,024.627
202006 6,654.410 104.870 7,541.350
202009 7,257.560 106.200 8,121.886
202012 6,644.158 105.765 7,465.985
202103 6,508.168 107.357 7,204.741
202106 7,178.540 107.579 7,930.508
202109 7,441.262 108.759 8,131.513
202112 7,446.703 109.676 8,069.407
202203 6,885.357 111.806 7,319.020
202206 7,742.875 114.083 8,066.272
202209 8,108.422 114.831 8,392.026
202212 8,058.004 115.200 8,313.139
202303 7,839.203 116.550 7,993.775
202306 8,446.540 117.140 8,569.683
202309 8,661.103 119.111 8,641.943
202312 8,368.584 118.848 8,368.584
202403 8,337.691 118.848 8,337.691

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dai Han Pharmaceutical Co  (XKRX:023910) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Dai Han Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Dai Han Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dai Han Pharmaceutical Co (XKRX:023910) Business Description

Traded in Other Exchanges
N/A
Address
8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR
Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co (XKRX:023910) Headlines

No Headlines